Sort
48,018 grants matching “immunotherapy”
Bladder Cancer Program
$1,057,180Andrea Apolo · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Developing novel LOX inhibitors to target chemotherapy resistant TNBC
$1,057,068Ozgur Sahin · Loxigen, Inc. · R42 · FY2025 · CA
PATHWAYS TO TOLERANCE IN HUMAN ISLET TRANSPLANTATION
$1,055,963University Of Miami School Of Medicine · R01 · FY2003 · DK
Determinants of response to cancer immunotherapy
$1,055,838Lawrence Fong · Fred Hutchinson Cancer Center · R35 · FY2025 · CA
ANTIGEN-SPECIFIC VACCINES FOR BREAST CANCER
$1,055,613Johns Hopkins University · U19 · FY2003 · CA
Integrating systems immunology with immunometabolism and cancer immunity
$1,055,460Hongbo Chi · St. Jude Children'S Research Hospital · R35 · FY2023 · CA
Integrating systems immunology with immunometabolism and cancer immunity
$1,055,460Hongbo Chi · St. Jude Children'S Research Hospital · R35 · FY2022 · CA
Investigation of role of microbiota in development, progression and therapy of cancers
$1,055,069Amiran Dzutsev · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Pathogenesis and countermeasures of poxviruses, hemorrhagic fever viruses, MERS
$1,054,912Peter Jahrling · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides
$1,054,354Dennis Klinman · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Collaborative Protein Technology Resource - Nano-Scale Protein Analysis Section
$1,053,823Noemi Kedei · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
Targeting eIF4A1 in drug-resistant breast cancer stem-like cells
$1,053,488Dayanidhi Raman · University Of Toledo Health Sci Campus · R01 · FY2025 · CA
FURTHER DEVELOPMENT OF COLOVAC, A MULTI-ANTIGEN MULTI-PEPTIDE VACCINE, FOR COLON CANCER PREVENTION
$1,052,768Clinton Grubbs · University Of Alabama At Birmingham · N01 · FY2019 · CA
Polyclonal Bi-Specific Vectored ImmunoTherapy to Functionally Cure HIV Infection
$1,052,100Alejandro Benjamin Balazs · Massachusetts General Hospital · DP1 · FY2024 · DA
Polyclonal Bi-Specific Vectored ImmunoTherapy to Functionally Cure HIV Infection
$1,052,100Alejandro Benjamin Balazs · Massachusetts General Hospital · DP1 · FY2025 · DA
Finding Sleeping Beauty: T Cell Biosensors for Dormant Cancer Detection
$1,052,030Gabriel A Kwong · Georgia Institute Of Technology · DP1 · FY2024 · CA
Adenosine Receptor Agonists as an Immunotherapy for Biodefense
$1,051,580Peter B Ernst · University Of Virginia · U01 · FY2007 · AI
A STINGing vaccine for TB
$1,051,436William Ramses Bishai · Johns Hopkins University · R01 · FY2022 · AI
Liver Cancer Program
$1,051,369Anuradha Budhu · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM IN AIDS
$1,051,286Beth Israel Medical Ctr (New York) · U01 · FY2001 · AI
Targeted immune therapies in heart transplantation
$1,050,893Reza Abdi · Brigham And Women'S Hospital · R35 · FY2023 · HL
Immune Escape in Human Cancer: Mechanisms and Therapeutic Implications
$1,050,724Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P01 · FY2010 · CA
Basic Research Support for the CCR
$1,050,724Robert Wiltrout · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA
Coordinating and Data Management Center for Acquired Resistance to Therapy Network
$1,050,404Alan David Hutson · Roswell Park Cancer Institute Corp · U24 · FY2022 · CA
Determining the contribution of microbial-derived metabolites to protective immunity in obesity-driven cancer risk.
$1,050,313Liza Makowski Hayes · University Of Tennessee Health Sci Ctr · U01 · FY2022 · CA